Truist Financial and Leerink Partners raised price objectives for Eli Lilly and Company stock.

The entities involved

• Eli Lilly and Company →

  American pharmaceutical company

  • Trade data and legislative control are currently influencing market sentiment and corporate operations.Sat 00:04
  • Agreement between Eli Lilly and Hims & Hers Health expands access to Lilly's medicines.Fri 14:13
• Truist Financial →

  American bank holding company, formerly known as BB&T Corporation

  • Keefe, Bruyette & Woods and Truist Financial both increased their price targets on November 6, 2026.Fri 23:18
  • Several financial firms, including Raymond James Financial and Truist Financial, issued multiple rating and price target updates on November 6, 2026.Fri 22:59
• Leerink partners →

  U.S. investment bank

  • Leerink Partners provided coverage and price targets for Freenome on September 26, 2026.Fri 19:28
  • Leerink Partners started coverage on ANI Pharmaceuticals shares.Fri 05:52

Related events

• Truist Financial, Leerink partners, and Morgan Stanley have raised price targets and weighed in on Incyte stock.Aug 6
• Leerink Partners and Barclays raised price targets on Elevance Health, while MarketBeat reported consensus ratings.Oct 21
• Truist Financial raised its price target and issued a buy rating for Builders FirstSource stock.Mon 15:52
• Truist Financial analysts dropped the target price for Deckers Outdoor on July 24, 2026.Jul 24
• Truist Financial boosted its price objective on Match Group stock.Aug 18